Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2777 participants.

Also called NCT01531374

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,777 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01531374
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01531374. Non-randomized; no masking; primary purpose treatment. Start 2012-02-21 (actual); primary completion 2015-11 (actual). Results posted on 2017-07-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
Condition
Severe Aortic Stenosis
Intervention (Device)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct01531374
Content hash
913ac1ee4de491f74306e5800f5a0b718cfc194589b5849eaf3b46d1ed3677f4